Skip to main content
Clinical Trials/ChiCTR2100044246
ChiCTR2100044246Active, not recruitingNot Applicable

瑞马唑仑在儿童镇静的应用

自筹1 site in 1 country130 target enrollmentStarted: March 20, 2021Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
130
Locations
1
Primary Endpoint
入睡时间

Study Overview

Brief Summary

探索瑞马唑仑在儿童镇静中的应用效果,安全性及适宜剂量。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
None

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1.患儿需要在镇静下完成的诊疗活动包括 CT,彩超,MRI,听力筛查等;

Exclusion Criteria

  • ①患儿两周内有上呼吸道感染及呼吸道发育异常者;
  • ②48 小时内接受过镇静麻醉药物者;
  • ③患儿有神经精神疾病;
  • ④严重贫血、肝肾功能异常者;
  • ⑥家长拒绝静脉注射者。

Arms & Interventions

瑞马唑仑组,右美托咪定组

瑞马唑仑静脉注射,右美托咪定滴鼻

丙泊酚组

丙泊酚静脉注射

Outcomes

Primary Outcomes

入睡时间

苏醒时间

镇静成功率

心率,呼吸,SPO2

副作用

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials